Oxford Nanopore Technologies
Latest round
- Series D
Last raised
- May 2011
Total raised
- $79M
Investors
- 5
About Oxford Nanopore Technologies
Based in Oxford, US, and founded in 2005 by co-founders Gordon Sanghera and Hagan Bayley, Oxford Nanopore Technologies Ltd. is a biotechnology company that focuses on producing nanopore sequencing products. In July 2015, the company published on nanopore sequencing of an influenza genome. The Company announced a chemical update to ‘R9' in March 2016, employing the protein nanopore CsgG in cooperation with Han Remaut's group (VIB/Vrije Universiteit Brussel), and the R9 nanopore was released in late May 2016. GridION was commercially released in 2017 and PromethION in 2018, with the device, the PromethION 48, started shipping in 2019. Flongle, a MinION/GridION adaptor was released in 2019. The company in 2021 has over 1,400 patents and patent applications spread over 200 patent families. The company's nanopore sequencing products include Minion, Gridion, Flongle, and Promethion, which are used to sequence and analyze biological samples, Voltrax, which is designed as an alternative to a variety of lab equipment, allowing the preparation of biological samples ready for analysis, sequencing kits, and flow cells. In development are Promethion p2, Smidgion, and Plongle, which employ nanopore technology. The company's products are utilized for DNA sequencing, RNA and gene expression analysis, and future protein analysis technologies. The company generates revenue from the sale of products, rendering services, and lease income. Oxford Nanopore Technologies has plans to get listed on the London stock market in the second half of 2021. The company also plans to purchase 150 million pounds of additional shares at Nanopore's forthcoming IPO in London.
Who invested in Oxford Nanopore Technologies
5 investors across 3 rounds
See all investors in Oxford Nanopore Technologies
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Oxford Nanopore Technologies
Who invested in Oxford Nanopore Technologies?
Oxford Nanopore Technologies has 5 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Oxford Nanopore Technologies raised?
Oxford Nanopore Technologies has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Oxford Nanopore Technologies last raise money?
Oxford Nanopore Technologies's most recent round on record is a Series D, in May 2011.
What does Oxford Nanopore Technologies do?
Based in Oxford, US, and founded in 2005 by co-founders Gordon Sanghera and Hagan Bayley, Oxford Nanopore Technologies Ltd.
Where is Oxford Nanopore Technologies headquartered?
Oxford Nanopore Technologies is headquartered in Oxford, UK.
Which VCs invest in companies like Oxford Nanopore Technologies?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at Oxford Nanopore Technologies's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series D
Raising like Oxford Nanopore Technologies? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.